N'-Hydroxy-2-methylpropanimidamide → 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-OL
反応式
[OH:1][CH:2]1[CH2:7][CH2:6][N:5]([C:8]#[N:9])[CH2:4][CH2:3]1.[OH:10]/[N:11]=[C:12](/N)\[CH:13]([CH3:15])[CH3:14]>C1COCC1.[Cl-].[Cl-].[Zn+2]>[CH:13]([C:12]1[N:9]=[C:8]([N:5]2[CH2:6][CH2:7][CH:2]([OH:1])[CH2:3][CH2:4]2)[O:10][N:11]=1)([CH3:15])[CH3:14]参加物
5
実験手順
To a stirred solution of 4-hydroxypiperidine-1-carbonitrile (0.4 g, 3.1 mmol) in THF (10 mL), (E)-N′-hydroxyisobutyrimidamide (0.35 g, 35 mmol) and ZnCl2 (1M solution in THF) (4.7 mL) were added and stirred at room temperature for 10 h. The reaction mixture was concentrated in vacuo and the resulting crude was dissolved in 4N HCl in ethanol-water (1:1) and stirred at 60-70° C. for 2-3 h. The reaction was quenched by saturated NaHCO3 and the organic layer was separated and concentrated. The residue on column chromatography gave the title compound. (0.280 g, 41.8%)
後処理
- concentrationThe reaction mixture was concentrated in vacuo
- dissolutionthe resulting crude was dissolved in 4N HCl in ethanol-water (1:1)
- stirringstirred at 60-70° C. for 2-3 h
- customThe reaction was quenched by saturated NaHCO3
- customthe organic layer was separated
- concentrationconcentrated
出典と根拠
- ORDレコード
- ord-89143c5012fb4e74b989f2a9b77c262d
- 出典データセット
- uspto-grants-2015_04
- 特許番号
- US09000175B2
反応ノート
読み込み中…